Is a mildly raised prolactin worth chasing during rapid loss?

My laboratory results are from the same laboratory each time, drawn fasting, which I gather matters.

The failure mode I am trying to avoid is making this decision emotionally.

I have twelve months in view and I would like the plan to survive that long.

What would you do, and what would make you change course?

Answering this needs the reference interval the laboratory used, because reference intervals for these analytes differ between methods enough to change a result from normal to abnormal.

Testosterone in males is both diurnal and pulsatile, and the conventional advice is an early-morning fasting sample repeated on a second occasion before anything is concluded.

The part that matters: growth-hormone secretion is pulsatile enough that IGF-1 is used as the integrated proxy, and IGF-1 itself is affected by nutritional status.

Diurnal variation for cortisol, testosterone and thyroid-stimulating hormone is characterised well enough that sampling time is part of the result rather than a detail about it.

Research-use compounds are not approved for human use, and self-experimentation with anything acting on an endocrine axis is a different risk category again.

Weight change moves several of these axes on its own, so attribution needs care.

Start with what is being measured and when. Most hormone assays are exquisitely sensitive to sampling time, fasting state and recent sleep, and those three explain a great many surprising results.

Thyroid-stimulating hormone has a diurnal variation of a few tenths and a wide reference interval, so small movements within the interval are not findings.

Ghrelin, peptide YY and glucagon-like peptide-1 itself all shift with sustained energy restriction, and those shifts partly oppose continued weight loss. That counter-regulation is a well-described phenomenon and is not specific to any drug.

The counter-regulatory hormonal response to weight loss is well documented in the physiological literature and persists for a long time after the loss itself.

Nothing here is medical advice, and an abnormal hormone result is a reason to see somebody rather than to read further here.

Record the draw time with the result, or the result is worth much less than you paid for it.

Pulsatile hormones cannot be characterised from a single sample, and several of the ones people ask about here are strongly pulsatile.

Sex-hormone-binding globulin rises as insulin resistance falls, which lowers free hormone fractions without any change in production. A free measure and a total measure can therefore move in opposite directions.

Mass spectrometry is the reference method for steroid quantification and immunoassays are known to over-read at the low end for several analytes.

The caveat is that endocrine results need a clinician who can see the whole panel and the person attached to it. This is background only.

Free and total measures can diverge through the binding protein. Read both.

Answer first: the class has documented effects on the gut hormone axis by design, and the claims that travel furthest are usually about axes it does not directly touch.

Leptin tracks fat mass closely and falls with weight loss, which is one of the mechanisms behind the counter-regulatory drive that makes maintenance harder than loss.

SELECT reported a hazard ratio of 0.80 (95% CI 0.72–0.90) for the primary composite major adverse cardiovascular event endpoint with semaglutide 2.4 mg in overweight or obese adults with established cardiovascular disease and without diabetes[1].

The caveat is the population. Trial participants were screened, monitored and supported; the effect size in an unmonitored setting is not the trial effect size, and it is not obvious in which direction the difference runs.

One abnormal value on a wide panel is usually statistics. Two on a repeat is a finding.